awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36903047-117063F1-6457-4D5F-9424-93F05C9911B5
Q36903047-117063F1-6457-4D5F-9424-93F05C9911B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36903047-117063F1-6457-4D5F-9424-93F05C9911B5
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer
P2860
Q36903047-117063F1-6457-4D5F-9424-93F05C9911B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36903047-117063F1-6457-4D5F-9424-93F05C9911B5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c30ea2876bbb49dd31fb56c7cc3b428c7186c82f
P2860
Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial.